ENB Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-05-04
- Employees
- 1
- Market Cap
- -
- Website
- http://www.enbpharma.com
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- MelanomaOvary CancerCancerPancreatic CancerSolid Tumor
- Interventions
- First Posted Date
- 2019-12-19
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- ENB Therapeutics, Inc
- Target Recruit Count
- 137
- Registration Number
- NCT04205227
- Locations
- 🇦🇺
Kinghorn-St Vincent's Hospital, Darlinghurst, New South Wales, Australia
🇦🇺Blacktown Oncology, Blacktown, New South Wales, Australia
🇺🇸Cedars Sinai-The Angeles Clinic, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath